(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide

C51H70N8O8 — CID 170074754

IUPAC(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide
SMILESCCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)C1=NC(CO1)C[C@H](NC(=O)[C@@H](COC1CN(C(=O)C#CC(C)(C)N(C)C)C1)C(C)C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C51H70N8O8/c1-12-58-42-18-17-33-23-37(42)38(45(58)36-15-13-21-52-44(36)32(4)64-11)25-50(5,6)30-67-49(63)40-16-14-22-59(55-40)48(62)41(24-34-28-66-47(33)53-34)54-46(61)39(31(2)3)29-65-35-26-57(27-35)43(60)19-20-51(7,8)56(9)10/h13,15,17-18,21,23,31-32,34-35,39-41,55H,12,14,16,22,24-30H2,1-11H3,(H,54,61)/t32-,34?,39-,40-,41-/m0/s1
InChIKeyNFKALJMZUMMPNO-SNXAYZFLSA-N
MW923.17 g/mol
LogP4.92
Rot. Bonds11

About (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide

(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide (PubChem CID 170074754) has the molecular formula C51H70N8O8 and a molecular weight of 923.17 g/mol. Its IUPAC name is (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide.

Molecular Properties

Compound Name(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide
PubChem CID170074754
Molecular FormulaC51H70N8O8
Molecular Weight923.17 g/mol
Exact Mass922.53
IUPAC Name(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide
SMILESCCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)C1=NC(CO1)C[C@H](NC(=O)[C@@H](COC1CN(C(=O)C#CC(C)(C)N(C)C)C1)C(C)C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C51H70N8O8/c1-12-58-42-18-17-33-23-37(42)38(45(58)36-15-13-21-52-44(36)32(4)64-11)25-50(5,6)30-67-49(63)40-16-14-22-59(55-40)48(62)41(24-34-28-66-47(33)53-34)54-46(61)39(31(2)3)29-65-35-26-57(27-35)43(60)19-20-51(7,8)56(9)10/h13,15,17-18,21,23,31-32,34-35,39-41,55H,12,14,16,22,24-30H2,1-11H3,(H,54,61)/t32-,34?,39-,40-,41-/m0/s1
InChIKeyNFKALJMZUMMPNO-SNXAYZFLSA-N
XLogP4.92
TPSA169.16 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms67
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500923.17
LogP ≤ 54.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide?
The IUPAC name of (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide (CID 170074754) is (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide.
What is the SMILES notation for (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide?
The canonical SMILES for (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide is CCn1c(-c2cccnc2[C@H](C)OC)c2c3cc(ccc31)C1=NC(CO1)C[C@H](NC(=O)[C@@H](COC1CN(C(=O)C#CC(C)(C)N(C)C)C1)C(C)C)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide?
The InChIKey is NFKALJMZUMMPNO-SNXAYZFLSA-N. The full InChI is InChI=1S/C51H70N8O8/c1-12-58-42-18-17-33-23-37(42)38(45(58)36-15-13-21-52-44(36)32(4)64-11)25-50(5,6)30-67-49(63)40-16-14-22-59(55-40)48(62)41(24-34-28-66-47(33)53-34)54-46(61)39(31(2)3)29-65-35-26-57(27-35)43(60)19-20-51(7,8)56(9)10/h13,15,17-18,21,23,31-32,34-35,39-41,55H,12,14,16,22,24-30H2,1-11H3,(H,54,61)/t32-,34?,39-,40-,41-/m0/s1.
What are the key properties of (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide?
(2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide has a molecular weight of 923.17 g/mol, XLogP of 4.92, 11 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[[1-[4-(dimethylamino)-4-methylpent-2-ynoyl]azetidin-3-yl]oxymethyl]-N-[(7S,13S)-21-ethyl-20-[2-[(1S)-1-methoxyethyl]-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-3,15-dioxa-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2(28),19,22(26),23-pentaen-7-yl]-3-methylbutanamide is sourced from PubChem (CID 170074754), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).